Autonomix Medical, Inc. Liquidation Value Calculator
Autonomix Medical, Inc.
Current Price: $0.37 (as of 2026-04-24)
Loading calculator data...
Advanced: All 78 XBRL Tags
Every XBRL tag from SEC EDGAR filings, grouped by financial statement type. total = may include children, fact = independent leaf value.
Balance Sheet
| Tag | Value | Unit | ||
|---|---|---|---|---|
| accounts_payable | ||||
| Accounts Payable Current total AccountsPayableCurrent |
$714,000 | USD | ||
| cash | ||||
| Cash And Cash Equivalents At Carrying Value total CashAndCashEquivalentsAtCarryingValue |
$9.93M | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations total CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations |
$9.93M | USD | ||
| current_liabilities | ||||
| Accrued Liabilities Current total AccruedLiabilitiesCurrent |
$936,000 | USD | ||
| liabilities_current | ||||
| Liabilities Current total LiabilitiesCurrent |
$1.65M | USD | ||
| liabilities_total | ||||
| Liabilities total | $1.65M | USD | ||
| shares_outstanding | ||||
| Common Stock Shares Outstanding total CommonStockSharesOutstanding |
11.4M | shares | ||
Unmapped Tags (70)
| Additional Paid In Capital AdditionalPaidInCapital | $72.98M | USD | ||
| Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued | $4.51M | USD | ||
| Assets Assets | $10.21M | USD | ||
| Assets Current AssetsCurrent | $10.19M | USD | ||
| Assets Fair Value Disclosure AssetsFairValueDisclosure | $0 | USD | ||
| Assets Noncurrent AssetsNoncurrent | $20,000 | USD | ||
| Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Common Stock Shares Authorized CommonStockSharesAuthorized | $500.00M | shares | ||
| Common Stock Shares Issued CommonStockSharesIssued | $11.41M | shares | ||
| Common Stock Value CommonStockValue | $11,000 | USD | ||
| Deferred Costs DeferredCosts | $0 | USD | ||
| Investment Income Interest InvestmentIncomeInterest | $248,000 | USD | ||
| Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity | $10.21M | USD | ||
| Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure | $0 | USD | ||
| Other Assets Current OtherAssetsCurrent | $257,000 | USD | ||
| Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Preferred Stock Shares Authorized PreferredStockSharesAuthorized | $10.00M | shares | ||
| Preferred Stock Shares Issued PreferredStockSharesIssued | $0 | shares | ||
| Preferred Stock Shares Outstanding PreferredStockSharesOutstanding | $0 | shares | ||
| Preferred Stock Value PreferredStockValue | $0 | USD | ||
| Property Plant And Equipment Net PropertyPlantAndEquipmentNet | $20,000 | USD | ||
| Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit | $-64.43M | USD | ||
| Stockholders Equity StockholdersEquity | $8.56M | USD | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | $2,000 | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | $798,000 | USD | ||
| Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction | $36,000 | USD | ||
| Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade | $2,000 | USD | ||
| Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities | $-95,000 | USD | ||
| Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets | $-216,000 | USD | ||
| Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims | $0 | USD | ||
| Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities | $10.20M | USD | ||
| Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities | $-7,000 | USD | ||
| Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities | $-9.39M | USD | ||
| Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts | $0 | USD | ||
| Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment | $7,000 | USD | ||
| Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants | $5.00M | USD | ||
| Proceeds From Warrant Exercises ProceedsFromWarrantExercises | $5,000 | USD | ||
| Share Based Compensation ShareBasedCompensation | $528,000 | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost | $3.70M | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised | $6.25M | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted | $15.07M | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber | $10.75M | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | $1,000 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | $40 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | $234,983 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | $5,000 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | $13,500 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | $5 | USD/shares | ||
| Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | $34 | USD/shares | ||
| Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | $2 | USD/shares | ||
| Advertising Expense AdvertisingExpense | $0 | USD | ||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | $10.76M | shares | ||
| Earnings Per Share Basic EarningsPerShareBasic | $-2 | USD/shares | ||
| General And Administrative Expense GeneralAndAdministrativeExpense | $8.61M | USD | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | $-14.05M | USD | ||
| Income Tax Expense Benefit IncomeTaxExpenseBenefit | $0 | USD | ||
| Interest Expense Nonoperating InterestExpenseNonoperating | $0 | USD | ||
| Net Income Loss NetIncomeLoss | $-14.05M | USD | ||
| Nonoperating Income Expense NonoperatingIncomeExpense | $248,000 | USD | ||
| Operating Expenses OperatingExpenses | $14.30M | USD | ||
| Operating Income Loss OperatingIncomeLoss | $-14.30M | USD | ||
| Research And Development Expense ResearchAndDevelopmentExpense | $5.68M | USD | ||
| Revenues Revenues | $0 | USD | ||
| Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding | $25,003 | shares | ||
| Depreciation Depletion And Amortization DepreciationDepletionAndAmortization | $9,000 | USD | ||
| Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent | $0 | USD | ||
| Number Of Reportable Segments NumberOfReportableSegments | $1 | pure | ||
| Stock Issued1 StockIssued1 | $1,000 | USD | ||
| Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues | $860,000 | USD | ||
| ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures | $961 | shares |
Showing balance sheet tags only. Liquidation analysis uses balance sheet data.